| Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices T Sturniolo, E Bono, J Ding, L Raddrizzani, O Tuereci, U Sahin, ... Nature biotechnology 17 (6), 555-561, 1999 | 923 | 1999 |
| Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer L De Monte, M Reni, E Tassi, D Clavenna, I Papa, H Recalde, M Braga, ... Journal of Experimental Medicine 208 (3), 469-478, 2011 | 728 | 2011 |
| Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines A Ronchetti, P Rovere, G Iezzi, G Galati, S Heltai, MP Protti, MP Garancini, ... The Journal of Immunology 163 (1), 130-136, 1999 | 350 | 1999 |
| Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11 S Manici, T Sturniolo, MA Imro, J Hammer, F Sinigaglia, C Noppen, ... The Journal of experimental medicine 189 (5), 871-876, 1999 | 339 | 1999 |
| Processing of engulfed apoptotic bodies yields T cell epitopes. M Bellone, G Iezzi, P Rovere, G Galati, A Ronchetti, MP Protti, J Davoust, ... Journal of immunology (Baltimore, Md.: 1950) 159 (11), 5391-5399, 1997 | 329 | 1997 |
| Loss of P53 function activates JAK2–STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient … SM Wörmann, L Song, J Ai, KN Diakopoulos, MU Kurkowski, K Görgülü, ... Gastroenterology 151 (1), 180-193. e12, 2016 | 244 | 2016 |
| The nicotinic acetylcholine receptor: structure and autoimmune pathology BM Conti-Tronconi, KE McLane, MA Raftery, SA Grando, MP Protti Critical Reviews in Biochemistry and Molecular Biology 29 (2), 69-123, 1994 | 193 | 1994 |
| Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer A Cachot, M Bilous, YC Liu, X Li, M Saillard, M Cenerenti, GA Rockinger, ... Science advances 7 (9), eabe3348, 2021 | 182 | 2021 |
| Identification of immunodominant regions among promiscuous HLA-DR–restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3 G Consogno, S Manici, V Facchinetti, A Bachi, J Hammer, BM Conti-Fine, ... Blood, The Journal of the American Society of Hematology 101 (3), 1038-1044, 2003 | 133 | 2003 |
| Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients L De Monte, S Wörmann, E Brunetto, S Heltai, G Magliacane, M Reni, ... Cancer research 76 (7), 1792-1803, 2016 | 131 | 2016 |
| Dendritic cell-derived IL2 production is regulated by IL15 both in humans and mice S Feau, V Facchinetti, F Granucci, S Citterio, D Jarrossay, S Seresini, ... Blood 7, 2004 | 127* | 2004 |
| Myasthenia gravis: recognition of a human autoantigen at the molecular level MP Protti, AA Manfredi, RM Horton, M Bellone, BM Conti-Tronconi Immunology today 14 (7), 363-368, 1993 | 127 | 1993 |
| Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients E Tassi, F Gavazzi, L Albarello, V Senyukov, R Longhi, P Dellabona, ... The Journal of Immunology 181 (9), 6595-6603, 2008 | 123 | 2008 |
| Immune infiltrates as predictive markers of survival in pancreatic cancer patients MP Protti, L De Monte Frontiers in physiology 4, 210, 2013 | 113 | 2013 |
| Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects MT Reding, H Wu, M Krampf, DK Okita, BM Diethelm-Okita, BA Christie, ... Thrombosis and haemostasis 84 (10), 643-652, 2000 | 108 | 2000 |
| Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis. MP Protti, AA Manfredi, C Straub, JF Howard Jr, BM Conti-Tronconi Proceedings of the National Academy of Sciences 87 (19), 7792-7796, 1990 | 91 | 1990 |
| Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer MP Protti, L De Monte OncoImmunology 1 (1), 0--1, 2012 | 86 | 2012 |
| In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen‐presenting cells M Bellone, G Iezzi, AA Manfredi, MP Protti, P Dellabona, G Casorati, ... European journal of immunology 24 (11), 2691-2698, 1994 | 72 | 1994 |
| Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif P Di Matteo, F Curnis, R Longhi, G Colombo, A Sacchi, L Crippa, ... Molecular immunology 43 (10), 1509-1518, 2006 | 71 | 2006 |
| Tumor antigen‐specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies MP Protti, LD Monte, GD Lullo Tissue Antigens 83 (4), 237-246, 2014 | 70 | 2014 |
